–News Direct– Genflow Biosciences PLC CE Dr Eric Leire tells Proactive's Stephen Gunnion the company had a successful year in 2023, allowing it to expand its research and development pipeline. Leire highlighted three main programs during an interview. The first focuses on MASH (Metabolic Dysfunction-Associated Steatohepatitis), soon progressing to clinical trials, indicating a strong move towards addressing liver diseases. The second program deals with Werner Syndrome, a progeria-related condition, where Genflow is innovating with synthetic organoids to mimic human organ

–News Direct– Eden Research PLC CEO Sean Smith tells Proactive's Stephen Gunnion the company achieved significant advancements and a robust performance in 2023. Revenue for the year to 31 December 2023 increased by 78% to 3.2 million, surpassing market expectations. This growth was attributed to strong sales across various product lines. A noteworthy development was a successful fundraising event that raised 9.9 million, enhancing the firm's cash position and enabling further product development. In partnership with Corteva Agriscience, Eden introduced

–News Direct– First Tin PLC CEO Bill Scotting joins Proactive's Stephen Gunnion with details of the two tin mining projects the company is developing in Australia and Germany. Scotting said the Taronga project, near Brisbane, will operate as an open pit mine and is expected to produce approximately 3,500 tonnes of tin concentrate annually. The German project, Tellerhuser is being developed as an underground mine and will target multiple metals, including tin, indium, copper, and zinc. Both projects are situated

India, 9th May 2024, King NewsWire – Ksolves India Limited, a publicly listed company, proudly announces its successful participation as a Platinum Sponsor at the prestigious Global AI Show held on April 16th and 17th. The event, a melting pot of innovation and expertise in artificial intelligence, witnessed Ksolves showcasing its prowess in AI and Big Data alongside engaging with industry luminaries and enthusiasts from across the globe. At the heart of Ksolves’ presence was its Chief Technology Officer (CTO), whose

–News Direct– Light Science Technologies Holdings PLC (AIM:LST) reported a record year in 2023 with CEO Simon Deacon highlighting significant achievements in an interview with Proactive's Stephen Gunnion. The company implemented a strategic plan focused on growth and profitability, exceeding expectations in both areas. Notably, its Controlled Environment Agriculture (CEA) segment and Contract Electronics Manufacturing (CEM) contributed robustly to revenue increases. The company achieved a gross margin of 23.4% and overall revenue growth of 13.8% to 9.3 million. Deacon also

–News Direct– Fah Mai Holdings Group Inc (OTC:FMHG) UK head and manager of @whiskybullauctions Jacob Carter provides detailed advice for investors in the secondary whisky bottle market in an interview with Proactive's Stephen Gunnion. Carter emphasised the importance of conducting thorough research and developing a personal investment strategy, highlighting rarity and age as key factors in choosing investment bottles. He mentioned significant past investment successes, such as a 1964 Black Bowmore Aston Martin DB5 bottle bought for less than 100

–News Direct– Seeing Machines Ltd CEO Paul McGlone joins Proactive's Stephen Gunnion with an update on the company's progress and key developments. McGlone highlighted the expansion with an existing US customer and a tier 1 supplier, driven by increasing regulatory requirements in Europe, which signifies a significant development for the company. This expansion includes new technology integrations and a stronger foothold in the European market, alongside additional volume in China. Further, McGlone discussed the company's recent performance following their third-quarter

–News Direct– Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt takes Proactive's Stephen Gunnion through the company's first-quarter achievements and upcoming milestones for its clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Vitt said the quarter was notable for Immunic's successful fundraising efforts, raising up to $240 million in a three-tranche private placement aimed at furthering its Multiple Sclerosis (MS) and gastrointestinal treatments. He also highlighted the importance of the recent allowance of a fourth

–News Direct– SosTravel.com (OTCQB:SOSAF, EURONEXT:SOS) investor relations head Edoardo Zarghetta outlines the company's operations and strategic directions in an interview with Proactive's Stephen Gunnion. Sostravel.com operates primarily as a digital travel technology company with two business units. One focuses on packaging holidays, primarily in destinations such as Sardinia, southern Italy, Kenya, Turkey, Egypt, and Cuba, managing hotels and resorts to create custom holiday packages. The second unit provides technology services, including a Lost Luggage Concierge and Dr Travel for telehealth

–News Direct– One Health Group PLC (AQSE:OHGR) CEO Adam Binns joined Proactive's Stephen Gunnion with details of a full-year trading update that showed revenue of more than 23 million for the year to 31 March 2024, and net year-end cash of 4.7 million, which will fund investment in future growth and underpin its progressive dividend policy. Binns explained that One Health Group operates as an independent provider of NHS services in the UK, specifically targeting various local economies with subcontracted